Brief: Enlivex Therapeutics Says On October 22, Co Entered Into At-The-Market Agreement With H.C. Wainwright & Co
22/10/2020 13:49
Oct 22 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX THERAPEUTICS SAYS ON OCTOBER 22, CO ENTERED INTO
AT-THE-MARKET AGREEMENT WITH H.C. WAINWRIGHT & CO - SEC FILING
* ENLIVEX THERAPEUTICS SAYS MAY ELECT TO SELL ORDINARY
SHARES
HAVING AGGREGATE OFFERING PRICE OF UP TO ONLY $25.0 MILLION FROM
TIME TO TIME
Source: [ID:https://bit.ly/31u3SA4]
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment